DLD Video

Petra Schwille (Max Planck Institute of Biochemistry), Cyriac Roeding (Earli) and Simon Jacob (Technical University of Munich (TUM)) on stage at the DLD Munich 2026 conference. Credit: Karl-Josef Hildenbrand / picture alliance for DLD / Hubert Burda Media

Speakers

Anna Bauer-Mehren

Roche
Profile image of Anna Bauer-Mehren, Roche Diagnostics, in an office under neon lights.

Anna Bauer-Mehren heads the Integrated Clinical Analytics Chapter in Roche Diagnostics. Her team develops algorithms and AI-based solutions for clinical environments. Previously, Anna worked for more than ten years in Roche Pharma research and early development.

Profile Page

Simon Jacob

Technical University of Munich
Portrait of neurologist Prof. Simon Jacob, TUM, in front of a wall with a colorful pattern.

Neurologist Simon Jacob is a Professor for Translational Neurotechnology at Technical University of Munich. His research focuses on the cellular and circuit basis of cognitive brain functions. Prof. Jacob is developing technologies that can contribute to improving treatments for disorders in the domains of perception, memory and language.

Profile Page

Cyriac Roeding

Earli
Headshot portrait of Earli CEO Cyriac Roeding, wearing black-rimmed glasses, smiling at the camera.

Cyriac Roeding is a Silicon Valley-based German-American entrepreneur and angel investor. He serves as the Co-founder and CEO of Earli, an early cancer detection and treatment firm headquartered in South San Francisco. Earli is based on Synthetic Biopsy technology from Stanford University and is funded by leading venture captial firms including Andreessen Horowitz and Khosla Ventures.

Profile Page

Petra Schwille

Max Planck Institute of Biochemistry
Petra Schwille, Director, Max Planck Institute of Biochemistry


Petra Schwille is Director at the Max Planck Institute of Biochemistry in Martinsried near Munich where she leads the research department of Cellular and Molecular Biophysics. Her research aims to identify the minimal prerequisites for cellular life.

Profile Page

Fabian Theis

Helmholtz Munich
Headshot portrait of cell biologist Fabian Theis, Director Computational Health Center & Scientific Director of HelmholtzAI at Helmholtz Munich, smiling at the camera, photographed in front of a grey background.

Fabian Theis is the Director of the Helmholtz Munich Computational Health Center and Scientific Director of HelmholtzAI. He uses artificial intelligence to unlock the secrets of human cells, exploring the cellular mechanisms behind diseases. In 2023, was awarded the Gottfried Wilhelm Leibniz Prize for his pioneering work in the analysis, modelling and interpretation of genomic data.

Profile Page

More DLD Talks

Paola Antonelli, Lucia Pietroiusti, DLD All Stars

Interspecies Design

Paola Antonelli (MoMA) and Lucia Pietrouisti (Serpentine Galleries) call for principles of co-design with other species and leaving the superior position of the anthropocentric framework. The first step towards interspecies design, they argue,…
Video Details
Video preview: Keri Grieman (University of Oxford), Keegan McBride (Tony Blair Institute for Global Change), Marta Mucznik (International Crisis Group) and Andrew Keen (KeenOn) speak at the DLD Munich 2026 conference.

Innovation, Regulation & Geopolitics: Accelerating Europe’s Competitive Future

Three leading experts discuss Europe’s most pressing dilemma: how to remain competitive in an era where power increasingly trumps democratic values. Moderated by author Andrew Keen, this DLD26 expert panel brings together Keri…
Video Details
magnifiercrosschevron-downchevron-rightmenu-circle
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram